Asarina Pharma

Developer of drugs for the premenstrual dysphoric disorder (PMDD)

placeUmea, Vasterbotten County, Sweden calendar_todayFounded 2006 groups5 employees language asarinapharma.com

Registered entities

Innovation

7 patent families (5 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 303 times.

YearFilings
20161
20171
20184
20194
20205
20214
20222
20232
20241
20252

Investor mix

9 investors on record; lead investors include Idinvest Partners, Ergomed.

Investor typeCountShare
Venture capital444%
Private equity111%
Other / undisclosed444%
Coming soon